Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

Speaking Engagement Sponsorship

2016 World Stem Cell Summit

Wednesday, December 7th, 2016

Speaking Engagement Sponsorship

2016 World Stem Cell Summit

Wednesday, December 7th, 2016, 2:00 pm EST

Back to Events Listing

Fish is a proud sponsor of the 12th Annual World Stem Cell Summit in West Palm Beach, FL, December 6-9, 2016. ​Principals Peter Ludwig and Robert Sullivan will present Patent Law Update for Companies, Investors and Technology Transfer Offices on December 7.

Attendees will hear from over 225 speakers, connect with the world’s top thought leaders, decision makers, investors and influencers, all while staying on the cutting edge of hot topics and future trends. Details for Peter and Robert’s panel are below.

To learn more about the World Stem Cell Summit, click here.

Patent Law Update for Companies, Investors and Technology Transfer Offices
December 7, 2016, 2:00PM – 3:30PM ET

Peter Ludwig, Fish & Richardson

A Short Guide to IP Legal Documents, Terms and Agreements, or “I’ve signed one of these before but didn’t really understand what it meant”!

A brief review of legal documents, terminology and agreements customarily encountered in conjunction with inventions and patenting.

Robert Sullivan, Fish & Richardson

Eligibility for Patents on Diagnostics and Biotech Inventions – Where do we go from here?

Court decisions over the last few years have invalidated many U.S. patents on diagnostic methods, genes and naturally derived products as claiming ineligible subject matter – a brief review of the case law and Patent Office guidelines, and some tips on what to do now.

Timo Faltus, PhD, University of Leipzig

The Connection of Patents and Therapy Access in the EU

The presentation will illustrate the patent situation for stem cell related inventions within the EU and highlight the complex relation of the missing patent eligibility for inventions based on human embryonic stem cells and the uncertainties regarding market access for therapies based on human embryonic stem cells

 

Stay current with Fish Sign up for our Newsletter